SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-8.09%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$176M
AUM Growth
+$176M
(-27%)
Cap. Flow
-$44.2M
Cap. Flow
% of AUM
-25.09%
Top 10 Holdings %
Top 10 Hldgs %
39.96%
Holding
51
New
2
Increased
12
Reduced
17
Closed
13
Top Buys
| 1 |
Sanofi
SNY
|
$3.75M |
| 2 |
Eli Lilly
LLY
|
$3.73M |
| 3 |
Agilent Technologies
A
|
$3.56M |
| 4 |
Stryker
SYK
|
$2.09M |
| 5 |
Novo Nordisk
NVO
|
$1.67M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$7.43M |
| 2 |
CVS Health
CVS
|
$6.07M |
| 3 |
Labcorp
LH
|
$5.27M |
| 4 |
Globus Medical
GMED
|
$4.8M |
| 5 |
Community Health Systems
CYH
|
$3.56M |
Sector Composition
| 1 | Healthcare | 96.12% |
| 2 | Energy | 1.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$280B
| $7.96M | 4.52% |
15,500
-1,500
| -9% | -$770K |
|
2
McKesson
MCK
$86B
| $7.34M | 4.17% |
22,500
| – | – |
|
3
Humana
HUM
$37.3B
| $7.26M | 4.12% |
15,500
-2,500
| -14% | -$1.17M |
|
4
Elevance Health
ELV
$72.6B
| $7.24M | 4.11% |
15,000
| – | – |
|
|
5
Eli Lilly
LLY
$659B
| $6.97M | 3.96% |
21,502
+11,502
| +115% | +$3.73M |
|
6
Boston Scientific
BSX
$158B
| $6.9M | 3.92% |
185,000
-15,000
| -8% | -$559K |
|
7
Thermo Fisher Scientific
TMO
$184B
| $6.79M | 3.86% |
12,500
| – | – |
|
|
8
Novo Nordisk
NVO
$251B
| $6.69M | 3.8% |
60,000
+15,000
| +33% | +$1.67M |
|
9
Danaher
DHR
$146B
| $6.59M | 3.75% |
26,000
-1,500
| -5% | -$380K |
|
10
Cigna
CI
$80.3B
| $6.59M | 3.74% |
25,000
+5,000
| +25% | +$1.32M |
|
11
Centene
CNC
$14.5B
| $6.35M | 3.61% |
75,000
+5,000
| +7% | +$423K |
|
|
12
Stryker
SYK
$149B
| $6.07M | 3.45% |
30,500
+10,500
| +53% | +$2.09M |
|
13
Cencora
COR
$57.2B
| $5.66M | 3.22% |
40,000
| – | – |
|
14
Zimmer Biomet
ZBH
$20.8B
| $5.25M | 2.98% |
50,000
+10,000
| +25% | +$1.05M |
|
15
Universal Health Services
UHS
$11.6B
| $4.78M | 2.72% |
47,500
| – | – |
|
16
Acadia Healthcare
ACHC
$2.17B
| $4.73M | 2.69% |
70,000
+20,000
| +40% | +$1.35M |
|
17
HCA Healthcare
HCA
$95B
| $4.62M | 2.63% |
27,500
+5,000
| +22% | +$840K |
|
18
Johnson & Johnson
JNJ
$429B
| $4.44M | 2.52% |
25,000
-10,000
| -29% | -$1.78M |
|
19
Abbott
ABT
$229B
| $4.35M | 2.47% |
40,000
-5,000
| -11% | -$543K |
|
20
Baxter International
BAX
$12.4B
| $4.18M | 2.37% |
65,000
+5,000
| +8% | +$321K |
|
21
Intuitive Surgical
ISRG
$168B
| $4.01M | 2.28% |
20,000
-2,500
| -11% | -$502K |
|
22
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.94M | 2.24% |
47,500
+7,500
| +19% | +$621K |
|
23
IQVIA
IQV
$31.2B
| $3.8M | 2.16% |
17,500
-2,500
| -13% | -$542K |
|
|
24
Sanofi
SNY
$121B
| $3.75M | 2.13% |
+75,000
| New | +$3.75M |
|
|
25
SPDR S&P Biotech ETF
XBI
$5.25B
| $3.71M | 2.11% |
50,000
-100,000
| -67% | -$7.43M |
|